Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **glutamate receptor subunit AMPA** (commonly called the AMPA receptor or AMPAR) is a **tetrameric ligand-gated ion channel** found throughout the mammalian central nervous system. It is composed of combinations of four subunits (GluA1, GluA2, GluA3, GluA4, encoded by GRIA1–4) that assemble to create the core pore for ion flow. When the endogenous neurotransmitter glutamate binds to the receptor, it triggers the rapid opening of the channel, allowing mainly sodium (Na⁺) and, depending on subunit composition, calcium (Ca²⁺) ions to flow into the postsynaptic neuron, generating fast excitatory postsynaptic potentials. AMPA receptors are central to brain functions such as learning, memory, and synaptic plasticity. Their surface expression, trafficking, and functional properties are extensively regulated by auxiliary subunits and post-transcriptional modifications. Dysregulation of AMPA receptors is implicated in conditions such as epilepsy, stroke, and neurodegeneration. Several drugs, including antagonists for epilepsy and positive allosteric modulators for cognitive enhancement, target AMPA receptors due to their crucial role in synaptic transmission and neuronal excitability[1][2][3][4].
Antagonists block ion conduction by inhibiting glutamate binding or channel opening - Positive allosteric modulators (AMPAkines) enhance receptor-mediated currents - Negative allosteric modulators reduce activity by decreasing channel opening or glutamate affinity
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor subunit AMPA (AMPAR).